This controversial finding also is seen in other tumors; for instance, patients with hepatocellular or colon carcinomas whose tumors express MMP12 mRNA have better survival than those whose tumors do not express MMP12 and thus do not produce angiostatin (41, 42). This evidence concerns the gene MMP12 and colon carcinoma.